Evaluating equity-promoting interventions to prevent race-based inequities in influenza outcomes.

Erin Stafford, Dobromir Dimitrov, Susan Brown Trinidad, Laura Matrajt
Author Information
  1. Erin Stafford: Department of Applied Mathematics, University of Washington, Seattle, WA, USA.
  2. Dobromir Dimitrov: Department of Applied Mathematics, University of Washington, Seattle, WA, USA.
  3. Susan Brown Trinidad: Department of Bioethics and Humanities, University of Washington, Seattle, WA, USA.
  4. Laura Matrajt: Department of Applied Mathematics, University of Washington, Seattle, WA, USA.

Abstract

Importance: Seasonal influenza hospitalizations pose a considerable burden in the United States, with BIPOC (Black, Indigenous, and other People of Color) communities being disproportionately affected.
Objective: To determine and quantify the effects of different types of mitigation strategies on inequities in influenza outcomes (symptomatic infections and hospitalizations).
Design: In this simulation study, we fit a race-stratified agent-based model of influenza transmission to demographic and hospitalization data of the United States.
Participants: We consider five racial-ethnic groups: non-Hispanic White persons, non- Hispanic Black persons, non-Hispanic Asian persons, non-Hispanic American Indian or Alaska Native persons, and Hispanic or Latino persons.
Setting: We tested five idealized equity-promoting interventions to determine their effectiveness in reducing inequity in influenza outcomes. The interventions assumed equalized vaccination rates, equalized comorbidities, work-risk distribution proportional to the distribution of the population, reduced work contacts for all, or a combination of equalizing vaccination rates and comorbidities and reducing work contacts.
Main Outcomes and Measures: Reduction in symptomatic or hospitalization risk ratios, defined as the ratio of the number of symptomatic infections (hospitalizations respectively) in each age- and racial-ethnic group and their corresponding white counterpart. We also evaluated the reduction in the absolute mean number of symptomatic infections or hospitalizations in each age- and racial-ethnic group compared to the fitted scenario (baseline).
Results: Our analysis suggests that symptomatic infections were equalized and reduced (by up to 17% in BIPOC adults aged 18-49) by strategies reducing work contacts or equalizing vaccination rates. Reducing comorbidities resulted in significant decreases in hospitalizations, with a reduction of over 40% in BIPOC groups. All tested interventions reduced the inequity in influenza hospitalizations in all racial-ethnic groups, but interventions reducing comorbidities in marginalized populations were the most effective. Notably, these interventions resulted in better outcomes across all racial-ethnic groups, not only those prioritized by the interventions.
Conclusions and Relevance: In this simulation modeling study, equalizing vaccination rates and reducing number of work contacts (which are relatively simple strategies to implement) reduced the both the inequity in hospitalizations and the absolute number of symptomatic infections and hospitalizations in all age and racial-ethnic groups.

Keywords

References

  1. Nat Hum Behav. 2022 Nov;6(11):1503-1514 [PMID: 36008683]
  2. J Med Ethics. 2015 Jan;41(1):99-102 [PMID: 25516947]
  3. MMWR Morb Mortal Wkly Rep. 2022 Oct 28;71(43):1366-1373 [PMID: 36302226]
  4. Clin Infect Dis. 2021 Feb 16;72(4):703-706 [PMID: 32562416]
  5. Vaccine. 2022 Mar 8;40(11):1643-1654 [PMID: 33933316]
  6. PLoS One. 2022 Jan 21;17(1):e0262172 [PMID: 35061776]
  7. BMJ Open. 2023 Apr 4;13(4):e067429 [PMID: 37015800]
  8. Clin Infect Dis. 2018 May 2;66(10):1511-1518 [PMID: 29206909]
  9. Theor Biol Med Model. 2020 Jul 10;17(1):11 [PMID: 32646444]
  10. Soc Sci Med. 2021 Jan;268:113554 [PMID: 33308911]
  11. PLoS Comput Biol. 2022 Feb 9;18(2):e1009795 [PMID: 35139067]
  12. BMC Public Health. 2021 Jun 17;21(1):1166 [PMID: 34140009]
  13. Am J Public Health. 2013 Jan;103(1):99-104 [PMID: 23153135]
  14. PLoS Med. 2011 Jun;8(6):e1000442 [PMID: 21713000]
  15. J Public Health Manag Pract. 2016 Jan-Feb;22 Suppl 1:S33-42 [PMID: 26599027]
  16. BMJ Glob Health. 2021 May;6(5): [PMID: 34039588]
  17. Vaccine. 2018 Jun 22;36(27):3960-3966 [PMID: 29801998]
  18. PNAS Nexus. 2023 Sep 09;2(9):pgad283 [PMID: 37693211]
  19. Health Equity. 2022 Mar 24;6(1):254-269 [PMID: 35402773]
  20. BMC Public Health. 2015 Sep 23;15:947 [PMID: 26400564]
  21. Adv Ther. 2023 Apr;40(4):1601-1627 [PMID: 36790682]
  22. Ann Fam Med. 2022 Mar-Apr;20(2):157-163 [PMID: 35045967]
  23. J Infect Dis. 2019 Jan 9;219(3):347-357 [PMID: 30016464]
  24. Open Forum Infect Dis. 2019 Feb 15;6(3):ofz053 [PMID: 30895200]
  25. Am J Epidemiol. 2004 Apr 1;159(7):623-33 [PMID: 15033640]
  26. Emerg Infect Dis. 2008 May;14(5):709-15 [PMID: 18439350]
  27. PLOS Glob Public Health. 2023 Feb 6;3(2):e0001378 [PMID: 36962865]
  28. Emerg Infect Dis. 2008 May;14(5):778-86 [PMID: 18439361]
  29. N C Med J. 2016 Sep-Oct;77(5):341-5 [PMID: 27621346]
  30. JAMA Netw Open. 2021 Aug 2;4(8):e2121880 [PMID: 34427679]
  31. BMC Public Health. 2014 Feb 11;14:147 [PMID: 24517715]
  32. Health Care Manag Sci. 2021 Sep;24(3):597-622 [PMID: 33970390]
  33. Vaccine. 2015 Dec 16;33(51):7160-7167 [PMID: 26562321]
  34. Pediatrics. 2023 Apr 1;151(4): [PMID: 36960655]
  35. MMWR Recomm Rep. 2019 Aug 23;68(3):1-21 [PMID: 31441906]
  36. Nature. 2004 Dec 16;432(7019):904-6 [PMID: 15602562]
  37. J Public Health Manag Pract. 2016 Jan-Feb;22 Suppl 1:S1-4 [PMID: 26599021]
  38. BMC Med. 2018 Sep 26;16(1):162 [PMID: 30253772]
  39. Nature. 2021 Jul;595(7866):205-213 [PMID: 34194045]
  40. Am J Public Health. 2011 Feb;101(2):285-93 [PMID: 21164098]
  41. Am J Epidemiol. 2008 Apr 1;167(7):775-85 [PMID: 18230677]
  42. Lancet. 2008 Nov 8;372(9650):1661-9 [PMID: 18994664]
  43. Value Health. 2017 Feb;20(2):206-212 [PMID: 28237196]
  44. Prev Med. 2022 Oct;163:107236 [PMID: 36058382]
  45. Emerg Infect Dis. 2022 Nov;28(11):2171-2180 [PMID: 36191624]
  46. SSM Popul Health. 2021 Jun 12;15:100845 [PMID: 34189244]
  47. Health Equity. 2022 Mar 07;6(1):206-223 [PMID: 35402775]
  48. PLoS Comput Biol. 2021 Jul 26;17(7):e1009149 [PMID: 34310589]
  49. Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2304750120 [PMID: 37549267]
  50. J Health Soc Behav. 2024 Mar;65(1):38-59 [PMID: 37776198]

Grants

  1. NU38OT000297/CDC HHS
  2. UM1 AI068635/NIAID NIH HHS
  3. UM1 AI148684/NIAID NIH HHS

Word Cloud

Created with Highcharts 10.0.0hospitalizationsinfluenzainterventionssymptomaticracial-ethnicinfectionspersonsreducingoutcomesvaccinationratescomorbiditiesreducedworkcontactsnumbergroupsBIPOCstrategiessimulationnon-HispanicinequityequalizedequalizingUnitedStatesBlackdetermineinequitiesstudyhospitalizationfiveHispanictestedequity-promotingdistributionage-groupreductionabsoluteresultedImportance:SeasonalposeconsiderableburdenIndigenousPeopleColorcommunitiesdisproportionatelyaffectedObjective:quantifyeffectsdifferenttypesmitigationDesign:fitrace-stratifiedagent-basedmodeltransmissiondemographicdataParticipants:considergroups:Whitenon-AsianAmericanIndianAlaskaNativeLatinoSetting:idealizedeffectivenessassumedwork-riskproportionalpopulationcombinationMainOutcomesMeasures:ReductionriskratiosdefinedratiorespectivelycorrespondingwhitecounterpartalsoevaluatedmeancomparedfittedscenariobaselineResults:analysissuggests17%adultsaged18-49Reducingsignificantdecreases40%marginalizedpopulationseffectiveNotablybetteracrossprioritizedConclusionsRelevance:modelingrelativelysimpleimplementageEvaluatingpreventrace-basedcomputerequity

Similar Articles

Cited By